TITLE

Restructuring rocks reps

AUTHOR(S)
Koroneos, George
PUB. DATE
December 2008
SOURCE
Pharmaceutical Representative;Dec2008, Vol. 38 Issue 12, p8
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the announcement made by two pharmaceutical companies, Merck and GlaxoXmithKline, regarding their major layoffs and new restructured management. Richard Clark, president and CEO of Merck, declared that the company will be cutting 7,200 jobs which is equivalent to 12& of its workforce. While, GlaxoSmithKline, presented its plan to cut 1,00 sales jobs which reduces its 8,500 representatives to 7,500.
ACCESSION #
35648930

 

Related Articles

  • Industry shakeups lead to job losses in '08. Comer, Ben // Medical Marketing & Media;Dec2008, Vol. 43 Issue 12, p34 

    The article presents information on job cuts made by various pharmaceutical companies in 2008 due to global financial crises. Merck & Co. Inc.'s announcement in October 2008 to reorganize its business-and shed 6,800 employees in the process-caps a year of heavy job losses across the industry....

  • Merck CEO Clark: Marketing, sales positions could be cut. M. I. // Medical Marketing & Media;Feb2010, Vol. 45 Issue 2, p14 

    The article reports on the plan to lay off employees of Merck & Co. Inc. in the wake of its merger with Schering-Plough Corp.

  • Movers & SHAKERS.  // ICIS Chemical Business;12/15/2008, Vol. 274 Issue 22, p36 

    The article offers information on initiatives taken by notable people in the U.S. chemical industry. Chief executive officer (CEO) of Merck & Co. Inc. Richard Clark has announced creating a unit to make generic versions of biotech drugs. CEO of Sony Corp. Howard Stringer has decided to cut 8,000...

  • TOP STORIES.  // MondayMorning;10/29/2007, Vol. 15 Issue 43, p1 

    This section offers news briefs related to the pharmaceutical industry. Merck & Co., in Whitehouse Station, New Jersey reported earnings that beat the estimates of analysts. Merck reported a 62 percent increase in its third-quarter profit, as revenues jumped by double digits. GlaxoSmithKline Plc...

  • TOP 50.  // Pharmaceutical Executive;Sep2003 Supplement, Vol. 23, p30 

    Presents the top 50 pharmaceutical companies in the U.S. Pfizer; GlaxoSmith Kline; Merck.

  • Top 50 Pharmaceutical Companies of 2001. Sellers, L. J.; Feighan, Clare; Kelley, Gordon // Pharmaceutical Executive;May2002, Vol. 22 Issue 5, p60 

    Features the world's top 50 pharmaceutical industries in 2001. Pfizer; GlaxoSmithKline; Merck.

  • Brand Watch. Frederick, James; West, Diane // Drug Store News;9/24/2001, Vol. 23 Issue 14, p31 

    Presents news on the pharmaceutical industry as of September 24, 2001. Merck & Company's gain in Bayer Pharmaceuticals' voluntary market withdrawal of its top-selling drug Baycol; Why GlaxoSmithKline changed the container labeling for its antiepileptic drug Lamictal tablets; Approval received...

  • Untitled.  // Chemical Week;11/20/2002, Vol. 164 Issue 46, p44 

    Presents an update related to the pharmaceutical and fine chemicals industries as of November 2002. Appointment of David Pulman at GlaxoSmithKline; Decision of a U.S. District Court judge that upheld the patent of Merck & Co. for an osteoporosis drug.

  • Top 20 pharmaceutical companies.  // Modern Healthcare;1/7/2008, Vol. 38 Issue 1, p31 

    A list of the top 20 pharmaceutical companies ranked by U.S. sales from October 2006 to September 2007 is presented which includes Pfizer, GlaxoSmithKline, and Merck & Co.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics